Search Results 2831-2840 of 18389 for rheumatoid arthritis

  1. Antiphospholipid syndrome - Doctors and departments - Mayo Clinic

    Rheumatology · Vascular centers. Areas that research this condition. Neurology Research · By Mayo Clinic Staff · Request an appointment · Diagnosis & treatment.

  2. Antiphospholipid syndrome - Doctors and departments - Mayo Clinic

    Rheumatology · Vascular centers. Areas that research this condition. Neurology Research · By Mayo Clinic Staff · Request an appointment · Diagnosis & treatment.

  3. Antiphospholipid syndrome - Doctors and departments - Mayo Clinic

    Rheumatology · Vascular centers. Areas that research this condition. Neurology Research · By Mayo Clinic Staff · Request an appointment · Diagnosis & treatment.

  4. Science Saturday: Regenerative medicine at Mayo ramps up

    Shapiro told Campanini he was eligible for the first-ever randomized clinical trial exploring the safety of stem cells for arthritis. Despite limited ...

  5. Study Using Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms - Mayo Clinic

    Taking any of the following drugs at the time of study participation: epidermal growth factor receptor inhibitor, topoisomerase 1 inhibitor (camptothecin ...

  6. Medical Research & Education - Mayo Clinic News Network

    New CDC Analysis Finds Nearly 1 in 4 US Adults Has Arthritis. Sharon Theimer. November 7, 2013. Minnesota. Mayo Clinic Study: Uterine Fibroids Have Significant ...

  7. Real-world evidence study of regenerative medicine and shoulder surgery - Mayo Clinic News Network

    Platelet-rich plasma has shown potential to ease other conditions, such as knee arthritis. Clinical trials may offer more robust documentation of the ...

  8. A Study To Assess Efficacy And Safety Of Pembrolizumab With Or Without Sacituzumab Tirumotecan (MK- 2870) In Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) - Mayo Clinic

    * Has confirmation that either epidermal growth factor receptor (EGFR)-directed or anaplastic lymphoma kinase (ALK)-directed therapy is not indicated as ...

  9. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

    ... factor [VEGF] Trap) are allowed; Surgery within two weeks prior to registration; Significant hemorrhage (> 30mL bleeding/episode in previous 3 months) or ...

  10. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

    ... factor support;; Platelet count ≥ 50,000/mm^3 (*Untransfused);; PT/INR/aPTT ≤ 1.5 x ULN;; Total bilirubin ≤ 1.5 x ULN (unless it is due to Gilbert's ...